GALDERMA LABS LP FDA Approval NDA 021789

NDA 021789

GALDERMA LABS LP

FDA Drug Application

Application #021789

Documents

Letter2005-07-08
Letter2005-11-18
Letter2011-10-24
Label2005-11-18
Label2010-03-17
Label2011-11-04
Letter2010-03-09
Label2005-07-07
Review2006-09-26
Review2012-10-12
Label2022-03-17
Label2022-03-17
Letter2022-03-17
Letter2022-03-17

Application Sponsors

NDA 021789GALDERMA LABS LP

Marketing Status

Prescription001

Application Products

001GEL;TOPICAL1%1METROGELMETRONIDAZOLE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2005-06-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2006-08-29N/A
LABELING; LabelingSUPPL3AP2010-03-05STANDARD
LABELING; LabelingSUPPL4AP2011-10-19UNKNOWN
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2014-09-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2015-01-12STANDARD
LABELING; LabelingSUPPL9AP2022-03-16STANDARD
LABELING; LabelingSUPPL10AP2022-03-16STANDARD

Submissions Property Types

ORIG1Null31
SUPPL3Null6
SUPPL4Null6
SUPPL5Null0
SUPPL6Null0
SUPPL9Null7
SUPPL10Null15

TE Codes

001PrescriptionAB

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21789
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.